Once a high-flier lab test manufacturer with a market valuation of $2 billion, Cue Health of San Diego filed for Chapter 7 bankruptcy on May 28. Analysts now say the company is valued at about $15 million. Founded in 2010, Cue Health was developing a test system that consumers could use at home. Its components […]
June 10, 2024, Intelligence: Late-Breaking Lab News
- By Robert Michel
- > From the Volume XXXI, No. 8 - June 10, 2024 Issue
- Tags: Allina Health, arup laboratories, Atrium Health, Beverly Monahan, Beyond Results LLC, Biocartis, Bluetooth, Carilion Labs, Caris Diagnostics, CBLPath, Chapter 7, Competition and Markets Authority, COVID-19, Cue Health, FDA, Fierce Biotech, First Light Medical and Consulting LLC, Food and Drug Administration, FrontrunnerHC, initial public offering, IPO, John Erickson, LabCorp, LumiraDx, Modena Henderson, N-of-One, NeoGenomics, PathGroup, PierianDx, Poplar Healthcare, Roche, Roche Holdings, SARS-CoV-2, simplifyMD, Solstas Lab Partners, Ventana Medical Systems
